Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bernard R. Neustadt is active.

Publication


Featured researches published by Bernard R. Neustadt.


Archive | 2000

Piperazine derivatives useful as CCR5 antagonists

Bahige M. Baroudy; John W. Clader; Hubert Josien; Stuart W. McCombie; Brian Mckittrick; Michael W. Miller; Bernard R. Neustadt; Anandan Palani; Elizabeth M. Smith; Ruo W. Steensma; Jayaram R. Tagat; Susan F. Vice; Mark Laughlin; Eric J. Gilbert; Marc Labroli


Archive | 2002

ADENOSINE A2a RECEPTOR ANTAGONISTS

Bernard R. Neustadt; Neil Lindo; William J. Greenlee; Deen Tulshian; Lisa S. Silverman; Yan Xia; Craig D. Boyle; Samuel Chackalamannil


Journal of Medicinal Chemistry | 1997

Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.

Ho-Sam Ahn; Ana Bercovici; George Boykow; Alan Bronnenkant; Samuel Chackalamannil; Jason Chow; Renee Cleven; John A. Cook; Michael Czarniecki; Carol Domalski; Ahmad Fawzi; Michael V. Green; Asli Gündes; Ginny D. Ho; Malvina Laudicina; Neil Lindo; Ke Ma; Mahua Manna; Brian Mckittrick; Bita Mirzai; Terry Nechuta; Bernard R. Neustadt; Chester Puchalski; Kathryn Pula; Lisa S. Silverman; Elizabeth M. Smith; Andrew Stamford; Richard P. Tedesco; Hsingan Tsai; Deen Tulshian


Journal of Medicinal Chemistry | 2001

Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antagonist

Jayaram R. Tagat; Ruo W. Steensma; Stuart W. McCombie; Dennis V. Nazareno; Sue-Ing Lin; Bernard R. Neustadt; Kathleen Cox; Serena Xu; Lisa Wojcik; Michael G. Murray; Nicole Vantuno; and Bahige M. Baroudy; Julie M. Strizki


Journal of Medicinal Chemistry | 1988

Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines.

Elizabeth M. Smith; Gerald F. Swiss; Bernard R. Neustadt; Elijah H. Gold; Jane A. Sommer; Arthur Brown; Peter J.S. Chiu; Rosa Moran; Edmund J. Sybertz; Thomas Baum


Journal of Medicinal Chemistry | 1973

Aporphines. 8. Total synthesis and pharmacological evaluation of (plus or minus)-apomorphine, (plus or minus)-apocodeine, (plus or minus)-N-n-propylnorapomorphine, and (plus or minus)-N-n-propylnorapocodeine.

John L. Neumeyer; Bernard R. Neustadt; Kyung Oh; Klaus K. Weinhardt; Charles B. Boyce; Franklin J. Rosenberg; David G. Teiger


Journal of Medicinal Chemistry | 1989

Angiotensin converting enzyme inhibitors: spirapril and related compounds

Elizabeth M. Smith; Gerald F. Swiss; Bernard R. Neustadt; Paul McNamara; Elijah H. Gold; Edmund J. Sybertz; Thomas Baum


Journal of Pharmaceutical Sciences | 1970

Aporphines V: Total Synthesis of (±)-Apomorphine

John L. Neumeyer; Bernard R. Neustadt; Klaus K. Weinhardt


Archive | 2007

TREATING PAIN, DIABETES, AND DISORDERS OF LIPID METABOLISM

Joel M. Harris; Bernard R. Neustadt; Stephen C. Sorota; Andrew Stamford; Deen Tulshian; Brian Mckittrick


Journal of Organic Chemistry | 1969

Chemistry of aporphines. IV. Synthesis of aporphines via Reissert alkylation, photochemical cyclization, and the Pschorr cyclization route

John L. Neumeyer; K. H. Oh; Klaus K. Weinhardt; Bernard R. Neustadt

Collaboration


Dive into the Bernard R. Neustadt's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge